Sterol and Isoprenoid Research Consortium (STAIR)
Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation
The purpose of this study is to find out more about how Smith-Lemli-Opitz Syndrome (SLOS) affects body chemistry and health with the use of cholesterol supplementation.
Subjects must be diagnosed with Smith-Lemli-Opitz Syndrome. Males and females of all ages will be accepted into the study. Subjects must be willing to travel to OHSU or another STAIR site.
0 - 85
Healthy Volunteers Needed
Duration of Participation
Sharon Butcher, RN
National Institutes of Health